Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAY™ ...
Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback